Accueil >
Publications >
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial

Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial

1 mars 2015Radiotherapy and Oncology

DOI : 10.1016/j.radonc.2015.02.008

Auteurs

Antonin Levy, David Azria, Jean-Pierre Pignon, Anne Delarochefordiere, Isabelle Martel-Lafay, Emmanuel Rio, David Malka, Thierry Conroy, Laurent Miglianico, Yves Becouarn, Katty Malekzadeh, Julie Leclercq, Beata Juzyna, Patrick Ezra, Claire Lemanski, Eric Deutsch